healthcare stocks

Defence Therapeutics: Revolutionizing Immune-Related Therapies with ACCUM Technology
Healthcare

Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology.

May 3, 2023
Mulvihill ETFs - XLVE: U.S. Health Care Enhanced Yield ETF
ETFs

Mulvihill's XLVE ETF offers exposure to large-cap US healthcare stocks with 25% leverage used for purchasing additional shares to write options, generating income from option premiums while maintaining close to "full" exposure to underlying portfolio stocks.

April 19, 2023
Defence Therapeutics: Developing Immune-related Therapies for Cancer Treatment
Healthcare

Defence Therapeutics is a Canadian biotech company developing immune-related therapies for cancer treatment, including cancer vaccines, antibodies, and drug delivery vehicles.

April 19, 2023
Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial
Healthcare

Algernon is focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease.

October 28, 2022